STALEY CAPITAL ADVISERS’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57.2M | Buy |
2,035,654
+54,140
| +3% | +$1.44M | 2.42% | 16 |
|
|
2025
Q4 | $49.3M | Sell |
1,981,514
-82,126
| -4% | -$2.07M | 2.03% | 16 |
|
|
2025
Q3 | $52.6M | Sell |
2,063,640
-33,065
| -2% | -$816K | 2.16% | 15 |
|
|
2025
Q2 | $50.8M | Sell |
2,096,705
-83,068
| -4% | -$1.94M | 2.16% | 15 |
|
|
2025
Q1 | $55.2M | Buy |
2,179,773
+29,355
| +1% | +$768K | 2.5% | 13 |
|
|
2024
Q4 | $57.1M | Buy |
2,150,418
+73,594
| +4% | +$2M | 2.53% | 12 |
|
|
2024
Q3 | $60.1M | Sell |
2,076,824
-14,438
| -0.7% | -$421K | 2.69% | 12 |
|
|
2024
Q2 | $58.5M | Buy |
2,091,262
+591,016
| +39% | +$16.3M | 2.69% | 12 |
|
|
2024
Q1 | $41.6M | Buy |
1,500,246
+195,696
| +15% | +$5.43M | 1.94% | 17 |
|
|
2023
Q4 | $37.6M | Sell |
1,304,550
-41,637
| -3% | -$1.26M | 1.87% | 18 |
|
|
2023
Q3 | $44.7M | Buy |
1,346,187
+55,290
| +4% | +$1.96M | 2.46% | 13 |
|
|
2023
Q2 | $47.4M | Buy |
1,290,897
+50,173
| +4% | +$1.95M | 2.55% | 12 |
|
|
2023
Q1 | $50.6M | Buy |
1,240,724
+50,407
| +4% | +$2.18M | 2.83% | 12 |
|
|
2022
Q4 | $61M | Sell |
1,190,317
-9,820
| -0.8% | -$471K | 3.64% | 9 |
|
|
2022
Q3 | $52.5M | Sell |
1,200,137
-15,996
| -1% | -$777K | 3.36% | 8 |
|
|
2022
Q2 | $63.8M | Sell |
1,216,133
-3,397
| -0.3% | -$173K | 3.77% | 6 |
|
|
2022
Q1 | $63.1M | Buy |
1,219,530
+6,901
| +0.6% | +$358K | 3.19% | 9 |
|
|
2021
Q4 | $71.6M | Sell |
1,212,629
-37,965
| -3% | -$1.88M | 3.42% | 7 |
|
|
2021
Q3 | $53.8M | Sell |
1,250,594
-7,520
| -0.6% | -$333K | 2.88% | 9 |
|
|
2021
Q2 | $49.3M | Buy |
1,258,114
+37,575
| +3% | +$1.46M | 2.58% | 13 |
|
|
2021
Q1 | $44.2M | Buy |
1,220,539
+83,737
| +7% | +$2.97M | 2.46% | 13 |
|
|
2020
Q4 | $41.8M | Sell |
1,136,802
-65,284
| -5% | -$2.39M | 2.56% | 13 |
|
|
2020
Q3 | $41.9M | Sell |
1,202,086
-16,655
| -1% | -$584K | 2.9% | 9 |
|
|
2020
Q2 | $37.8M | Sell |
1,218,741
-108,140
| -8% | -$3.67M | 2.74% | 9 |
|
|
2020
Q1 | $41.1M | Buy |
1,326,881
+55,343
| +4% | +$1.89M | 3.45% | 7 |
|
|
2019
Q4 | $47.3M | Buy |
1,271,538
+18,618
| +1% | +$663K | 3.2% | 7 |
|
|
2019
Q3 | $42.7M | Buy |
1,252,920
+100,293
| +9% | +$3.65M | 3.2% | 9 |
|
|
2019
Q2 | $47.4M | Buy |
1,152,627
+21,318
| +2% | +$847K | 3.53% | 7 |
|
|
2019
Q1 | $45.6M | Buy |
1,131,309
+9,003
| +0.8% | +$361K | 3.37% | 9 |
|
|
2018
Q4 | $46.5M | Sell |
1,122,306
-50,624
| -4% | -$2.1M | 3.76% | 4 |
|
|
2018
Q3 | $49M | Buy |
1,172,930
+3,731
| +0.3% | +$144K | 3.43% | 9 |
|
|
2018
Q2 | $40.2M | Sell |
1,169,199
-2,709
| -0.2% | -$92.6K | 3.09% | 11 |
|
|
2018
Q1 | $39.5M | Buy |
1,171,908
+90,291
| +8% | +$3.1M | 3.1% | 11 |
|
|
2017
Q4 | $37.2M | Buy |
1,081,617
+5,829
| +0.5% | +$199K | 2.88% | 11 |
|
|
2017
Q3 | $36.4M | Buy |
1,075,788
+1,795
| +0.2% | +$57.7K | 2.98% | 11 |
|
|
2017
Q2 | $34.2M | Buy |
1,073,993
+18,330
| +2% | +$578K | 2.92% | 10 |
|
|
2017
Q1 | $34.3M | Sell |
1,055,663
-1,887
| -0.2% | -$59.5K | 3.06% | 11 |
|
|
2016
Q4 | $32.6M | Buy |
1,057,550
+51,531
| +5% | +$1.57M | 3.13% | 10 |
|
|
2016
Q3 | $32.3M | Buy |
1,006,019
+5,262
| +0.5% | +$176K | 3.23% | 9 |
|
|
2016
Q2 | $33.4M | Buy |
1,000,757
+9,200
| +0.9% | +$294K | 3.5% | 7 |
|
|
2016
Q1 | $27.9M | Buy |
991,557
+34,214
| +4% | +$977K | 3.01% | 9 |
|
|
2015
Q4 | $29.3M | Buy |
957,343
+22,354
| +2% | +$703K | 3.38% | 8 |
|
|
2015
Q3 | $27.9M | Buy |
934,989
+76,109
| +9% | +$2.44M | 3.39% | 7 |
|
|
2015
Q2 | $27.3M | Buy |
858,880
+18,791
| +2% | +$612K | 3.04% | 9 |
|
|
2015
Q1 | $27.7M | Buy |
840,089
+8,019
| +1% | +$255K | 3.2% | 6 |
|
|
2014
Q4 | $24.6M | Buy |
832,070
+7,629
| +0.9% | +$219K | 2.86% | 11 |
|
|
2014
Q3 | $23.1M | Buy |
824,441
+17,896
| +2% | +$502K | 2.76% | 12 |
|
|
2014
Q2 | $22.7M | Buy |
806,545
+110,300
| +16% | +$3.14M | 2.72% | 10 |
|
|
2014
Q1 | $21.2M | Buy |
696,245
+3,296
| +0.5% | +$98.3K | 2.69% | 11 |
|
|
2013
Q4 | $20.1M | Sell |
692,949
-4,280
| -0.6% | -$125K | 2.74% | 11 |
|
|
2013
Q3 | $19M | Buy |
697,229
+21,491
| +3% | +$585K | 2.89% | 9 |
|
|
2013
Q2 | $18M | Buy |
+675,738
| New | +$18.7M | 2.9% | 9 |
|
Other funds holding PFE
VCM
VPM
STALEY CAPITAL ADVISERS's PFE Position: Q1 2026 in Review
STALEY CAPITAL ADVISERS increased its Pfizer (PFE) stake by 2.7% in Q1 2026, buying an estimated $1.44M and bringing the position to 2,035,654 shares worth $57.2M. The position accounts for 2.42% of the portfolio, ranked #16.
STALEY CAPITAL ADVISERS first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $71.6M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- STALEY CAPITAL ADVISERS held 2,035,654 shares of Pfizer worth $57.2M as of Q1 2026.
- STALEY CAPITAL ADVISERS bought 54,140 Pfizer shares in Q1 2026, an estimated $1.44M.
- Pfizer made up 2.42% of STALEY CAPITAL ADVISERS's portfolio in Q1 2026, its #16 holding.
- STALEY CAPITAL ADVISERS first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- STALEY CAPITAL ADVISERS's Pfizer position peaked at $71.6M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2026, filed 29 Apr 2026.